| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
ABVC Biopharma, Inc.
13D/A
ABVC · 00091F304
|
18.5% |
7/15/2025
Event 7/10/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.